Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.

MLA

He, Zhenxing, et al. “Nobiletin Attenuates Lipopolysaccharide/D‑galactosamine‑induced Liver Injury in Mice by Activating the Nrf2 Antioxidant Pathway and Subsequently Inhibiting NF‑κB‑mediated Cytokine Production.” Molecular Medicine Reports, vol. 14, no. 6, Dec. 2016, pp. 5595–600. EBSCOhost, https://doi.org/10.3892/mmr.2016.5943.

APA

He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., & Gong, J. (2016). Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production. Molecular Medicine Reports, 14(6), 5595–5600. https://doi.org/10.3892/mmr.2016.5943

Chicago

He, Zhenxing, Xuanfei Li, Hao Chen, Kun He, Yiming Liu, Junhua Gong, and Jianping Gong. 2016. “Nobiletin Attenuates Lipopolysaccharide/D‑galactosamine‑induced Liver Injury in Mice by Activating the Nrf2 Antioxidant Pathway and Subsequently Inhibiting NF‑κB‑mediated Cytokine Production.” Molecular Medicine Reports 14 (6): 5595–5600. doi:10.3892/mmr.2016.5943.